PET scans reveal where experimental cancer drug travels
NCT ID NCT05638334
First seen Feb 18, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This early-stage study aimed to see how a new drug called S095012 spreads through the body and reaches tumors in people with advanced solid cancers. Only 3 participants were enrolled before the study was stopped early. The main goal was to use PET scans to track the drug, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UMC Gronningen Oncologie
Groningen, 9713 AZ, Netherlands
Conditions
Explore the condition pages connected to this study.